Cyclic triterpenoid production with tailored Saccharomyces cerevisiae by Ebert, Birgitta E. et al.
CYCLIC TRITERPENOID PRODUCTION WITH TAILORED SACCHAROMYCES CEREVISIAE 
 
Birgitta E, Ebert, iAMB - Institute of Applied Microbiology, RWTH Aachen University, Aachen, Germany 
birgitta.ebert@rwth-aachen.de   
Eik Czarnotta, Kerstin Walter, Lars M. Blank, iAMB - Institute of Applied Microbiology, RWTH Aachen University, 
Aachen, Germany  
Christoph Knuf, Jérôme Maury, Simo A. Jacobsen, Jochen Förster, Novo Nordisk Foundation Center for 
Biosustainability, DTU Denmark, Denmark  
Anna Lewandowski, Thomas Polakowski, Christine Lang, Organobalance GmbH, Berlin, Germany  
 
Key Words: Saccharomyces cerevisiae, triterpenoid, metabolic engineering, process optimization  
 
Triterpenoids are secondary plant metabolites derived from squalene and consist of six isoprene units (C30). 
Many of them or their synthetic derivatives are currently being investigated as medicinal products for various 
diseases. The cyclic triterpenoid betulinic acid is of special interest for the pharmaceutical and nutritional 
industry as it has antiretroviral, antimalarial, and anti-inflammatory properties and has potential as an anticancer 
agent (Muffler et al. 2011, Mullauer et al. 2010). Despite their obvious industrial potential, the application is often 
hindered by their low abundance in natural plant sources. This poses challenges in a biosustainable production 
of such compounds due to wasteful and costly product purification. 
Here, we present a novel biotechnological process for the production of betulinic acid using tailored 
Saccharomyces cerevisiae strains. The multi-scale optimization of this microbial process included:  
- pathway engineering by determination of optimal gene combination and dosage,  
- compartment engineering to increase the reaction space of the betulinic acid pathway, and 
- strain engineering by implementation of different push, pull and block strategies.  
In parallel we developed the fermentation process and were able to boost the performance of the engineered 
yeast by optimization of medium composition, cultivation conditions, carbon source and mode of fermentation 
operation in lab scale bioreactors. Product purification was achieved by a one-step extraction with acetone.  
The final process was evaluated in terms of economic and ecological efficiency and rated to be competitive with 
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Figure 1 – Strain and process optimization strategies for betulinic acid production in S. cerevisiae. 
